HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 202 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2023. The put-call ratio across all filers is 0.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,169 | -17.8% | 35,685 | -11.7% | 0.06% | -11.3% |
| Q2 2023 | $1,422 | +218.8% | 40,415 | +195.8% | 0.06% | +195.2% |
| Q1 2023 | $446 | -53.4% | 13,665 | -21.4% | 0.02% | -60.4% |
| Q4 2022 | $958 | -99.9% | 17,393 | +15.9% | 0.05% | +32.5% |
| Q3 2022 | $664,000 | -10.9% | 15,003 | -1.8% | 0.04% | -28.6% |
| Q2 2022 | $745,000 | -39.4% | 15,285 | -39.5% | 0.06% | -30.9% |
| Q1 2022 | $1,230,000 | – | 25,281 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $618,113,619 | 97.50% |
| venBio Partners LLC | 1,035,396 | $57,050,320 | 17.69% |
| Vivo Capital, LLC | 2,606,247 | $143,604 | 16.53% |
| Nan Fung Group Holdings Ltd | 368,665 | $20,313,442 | 14.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $14,560,725 | 4.50% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 685,340 | $37,762,234 | 3.51% |
| ASHFORD CAPITAL MANAGEMENT INC | 356,638 | $19,650,754 | 3.05% |
| TANG CAPITAL MANAGEMENT LLC | 281,200 | $15,494,120 | 2.25% |
| MPM BioImpact LLC | 139,377 | $7,679,673 | 1.99% |
| O'Neil Global Advisors, Inc. | 7,335 | $404 | 1.86% |